FENC
Price:
$5.29
Market Cap:
$144.76M
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.[Read more]
Industry
Biotechnology
IPO Date
2017-09-15
Stock Exchange
NASDAQ
Ticker
FENC
According to Fennec Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 75.57. This represents a change of -639.29% compared to the average of -14.01 of the last 4 quarters.
The mean historical PE Ratio of Fennec Pharmaceuticals Inc. over the last ten years is -13.93. The current 75.57 PE Ratio has changed -54351.65% with respect to the historical average. Over the past ten years (40 quarters), FENC's PE Ratio was at its highest in in the March 2015 quarter at 36.40. The PE Ratio was at its lowest in in the September 2015 quarter at -44.65.
Average
-13.93
Median
-11.28
Minimum
-28.66
Maximum
-6.56
Discovering the peaks and valleys of Fennec Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 134.84%
Maximum Annual PE Ratio = -6.56
Minimum Annual Increase = -174.97%
Minimum Annual PE Ratio = -28.66
Year | PE Ratio | Change |
---|---|---|
2023 | -18.25 | 79.70% |
2022 | -10.15 | 54.92% |
2021 | -6.56 | -33.47% |
2020 | -9.85 | -4.92% |
2019 | -10.36 | -15.21% |
2018 | -12.22 | -42.67% |
2017 | -21.32 | 119.32% |
2016 | -9.72 | -66.08% |
2015 | -28.66 | 134.84% |
2014 | -12.20 | -174.97% |
The current PE Ratio of Fennec Pharmaceuticals Inc. (FENC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.65
5-year avg
-11.03
10-year avg
-13.93
Fennec Pharmaceuticals Inc.’s PE Ratio is greater than Molecular Partners AG (-2.67), greater than MediciNova, Inc. (-12.61), greater than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Champions Oncology, Inc. (-7.94), greater than Cyteir Therapeutics, Inc. (-3.52), greater than Keros Therapeutics, Inc. (-11.28), greater than Janux Therapeutics, Inc. (-51.01), greater than Edgewise Therapeutics, Inc. (-14.14), greater than Harmony Biosciences Holdings, Inc. (17.58), less than Ikena Oncology, Inc. (0), greater than Aerovate Therapeutics, Inc. (-1.22), greater than Eliem Therapeutics, Inc. (-0.62), greater than Decibel Therapeutics, Inc. (-3.49), greater than Olema Pharmaceuticals, Inc. (-1.94), greater than Disc Medicine, Inc. (-6.07), greater than Larimar Therapeutics, Inc. (-14.19), greater than Orchestra BioMed Holdings, Inc. (-8.80), greater than null (-3.61),
Company | PE Ratio | Market cap |
---|---|---|
-2.67 | $182.90M | |
-12.61 | $103.00M | |
-4.99 | $46.68M | |
-7.94 | $57.77M | |
-3.52 | $108.71M | |
-11.28 | $1.97B | |
-51.01 | $2.15B | |
-14.14 | $1.64B | |
17.58 | $2.02B | |
0 | $81.56M | |
-1.22 | $54.85M | |
-0.62 | $495.57M | |
-3.49 | $123.37M | |
-1.94 | $677.46M | |
-6.07 | $1.50B | |
-14.19 | $513.64M | |
-8.80 | $212.20M | |
-3.61 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fennec Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Fennec Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Fennec Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Fennec Pharmaceuticals Inc. (FENC)?
What is the highest PE Ratio for Fennec Pharmaceuticals Inc. (FENC)?
What is the 3-year average PE Ratio for Fennec Pharmaceuticals Inc. (FENC)?
What is the 5-year average PE Ratio for Fennec Pharmaceuticals Inc. (FENC)?
How does the current PE Ratio for Fennec Pharmaceuticals Inc. (FENC) compare to its historical average?